The study aims to evaluate the effect of Litramine on fecal fat excretion in healthy subjects, to provide more comprehensive and robust clinical evidence in its mode of action for the treatment of obesity and weight management through dietary fat binding.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
20
Weißenseer Weg 111
Berlin, State of Berlin, Germany
Difference between Litramine and placebo in changes of percentage fecal fat excretion after intervention
The amount of fat excreted in the feces will be quantified by the near-infrared reflectance analysis (NIRA)
Time frame: 7 days per intervention
Full blood count
Analysis of hemoglobin, hematocrit, erythrocytes, thrombocytes, and leucocytes
Time frame: Approximately 45 days
Clinical chemistry
Liver function, renal function, protein metabolism, lipid metabolism
Time frame: Approximately 45 days
Blood pressure
Sitting blood pressure and heart rate will be measured using standard devices
Time frame: Approximately 45 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.